Clinical Trial Update: Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of Endostar in combination with chemotherapy for HER-2 negative advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN